Staar Surgical Shares Slide Following Preliminary 2Q Sales

Dow Jones

07/17

Staar Surgical shares retreated after forecasting second-quarter net sales slight below Wall Street's estimate.

Shares declined 12% to $25.36 in post-market trading on Thursday, after ending the market session up 1.7% at $28.98. The stock is up 26% this year.

The company said after the close it expects net sales of $90 million for the second quarter, just missing the $90.2 million analysts expect, according to FactSet. Staar generated net sales of $44.3 million in the same period a year ago.

Staar said the quarter was led by sequential growth in China, solid growth across Asia-Pacific, and double-digit percentage growth in the Americas.

In EMEA, net sales declined by a low-single-digit percentage, due to continuing turmoil in the Middle East. Excluding the Middle East, EMEA sales grew by double digits, proving strong underlying regional demand. The company also noted that geopolitical and macroeconomic headwinds continued to weigh on parts of EMEA and Asia-Pacific, and cautioned that persistent or broader challenges could affect sales.

Staar plans to report second-quarter results on August 12.

Write to Doc Louallen at Doc.Louallen@wsj.com

(END) Dow Jones Newswires

Staar Surgical shares retreated after forecasting second-quarter net sales. The company said after the close it expects net sales in excess of $90 million for the second quarter. Analysts are expecting sales of $90.2 million for the quarter, according to FactSet "Staar Surgical Shares Slide Following Preliminary 2Q Sales," at 6:04 p.m. ET on July 16, incorrectly said the company was expecting net sales of $90 million for the second quarter.

(END) Dow Jones Newswires

July 17, 2026 09:53 ET (13:53 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2652420394"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2652420394\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2652420394?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-17 06:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2652420394","market":"fut","top_or_hot":-1,"title":"Staar Surgical Shares Slide Following Preliminary 2Q Sales","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Staar Surgical shares retreated after forecasting second-quarter net sales slight below Wall Street's estimate. \n</p>\n<p>\n  Shares declined 12% to $25.36 in post-market trading on Thursday, after ending the market session up 1.7% at $28.98. The stock is up 26% this year. \n</p>\n<p>\n  The company said after the close it expects net sales of $90 million for the second quarter, just missing the $90.2 million analysts expect, according to FactSet. Staar generated net sales of $44.3 million in the same period a year ago. \n</p>\n<p>\n  Staar said the quarter was led by sequential growth in China, solid growth across Asia-Pacific, and double-digit percentage growth in the Americas. \n</p>\n<p>\n  In EMEA, net sales declined by a low-single-digit percentage, due to continuing turmoil in the Middle East. Excluding the Middle East, EMEA sales grew by double digits, proving strong underlying regional demand. The company also noted that geopolitical and macroeconomic headwinds continued to weigh on parts of EMEA and Asia-Pacific, and cautioned that persistent or broader challenges could affect sales. \n</p>\n<p>\n  Staar plans to report second-quarter results on August 12. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Doc Louallen at Doc.Louallen@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Staar Surgical shares retreated after forecasting second-quarter net sales. The company said after the close it expects net sales in excess of $90 million for the second quarter. Analysts are expecting sales of $90.2 million for the quarter, according to FactSet \"Staar Surgical Shares Slide Following Preliminary 2Q Sales,\" at 6:04 p.m. ET on July 16, incorrectly said the company was expecting net sales of $90 million for the second quarter. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 17, 2026 09:53 ET (13:53 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Staar Surgical Shares Slide Following Preliminary 2Q Sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStaar Surgical Shares Slide Following Preliminary 2Q Sales\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2026-07-17 06:04</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Staar Surgical shares retreated after forecasting second-quarter net sales slight below Wall Street's estimate. \n</p>\n<p>\n  Shares declined 12% to $25.36 in post-market trading on Thursday, after ending the market session up 1.7% at $28.98. The stock is up 26% this year. \n</p>\n<p>\n  The company said after the close it expects net sales of $90 million for the second quarter, just missing the $90.2 million analysts expect, according to FactSet. Staar generated net sales of $44.3 million in the same period a year ago. \n</p>\n<p>\n  Staar said the quarter was led by sequential growth in China, solid growth across Asia-Pacific, and double-digit percentage growth in the Americas. \n</p>\n<p>\n  In EMEA, net sales declined by a low-single-digit percentage, due to continuing turmoil in the Middle East. Excluding the Middle East, EMEA sales grew by double digits, proving strong underlying regional demand. The company also noted that geopolitical and macroeconomic headwinds continued to weigh on parts of EMEA and Asia-Pacific, and cautioned that persistent or broader challenges could affect sales. \n</p>\n<p>\n  Staar plans to report second-quarter results on August 12. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Doc Louallen at Doc.Louallen@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Staar Surgical shares retreated after forecasting second-quarter net sales. The company said after the close it expects net sales in excess of $90 million for the second quarter. Analysts are expecting sales of $90.2 million for the quarter, according to FactSet \"Staar Surgical Shares Slide Following Preliminary 2Q Sales,\" at 6:04 p.m. ET on July 16, incorrectly said the company was expecting net sales of $90 million for the second quarter. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 17, 2026 09:53 ET (13:53 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"STAA","symbol_name":"STAAR Surgical Company","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2652420394","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2652420394","pubTimestamp":1784239440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Staar Surgical shares retreated after forecasting second-quarter net sales slight below Wall Street's estimate.Shares declined 12% to $25.36 in post-market trading on Thursday, after ending the market session up 1.7% at $28.98. The stock is up 26% this year.The company said after the close it expects net sales of $90 million for the second quarter, just missing the $90.2 million analysts expect, according to FactSet. Staar generated net sales of $44.3 million in the same period a year ago.Staar said the quarter was led by sequential growth in China, solid growth across Asia-Pacific, and double-digit percentage growth in the Americas.In EMEA, net sales declined by a low-single-digit percentage, due to continuing turmoil in the Middle East. Excluding the Middle East, EMEA sales grew by double digits, proving strong underlying regional demand. The company also noted that geopolitical and macroeconomic headwinds continued to weigh on parts of EMEA and Asia-Pacific, and cautioned that persi","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"STAA":"STAAR Surgical Company"},"translate_title":"Staar Surgical 股价在第二季度初步销售后下滑","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STAA":1.5},"content_text":"Staar Surgical shares retreated after forecasting second-quarter net sales slight below Wall Street's estimate. \n\n\n  Shares declined 12% to $25.36 in post-market trading on Thursday, after ending the market session up 1.7% at $28.98. The stock is up 26% this year. \n\n\n  The company said after the close it expects net sales of $90 million for the second quarter, just missing the $90.2 million analysts expect, according to FactSet. Staar generated net sales of $44.3 million in the same period a year ago. \n\n\n  Staar said the quarter was led by sequential growth in China, solid growth across Asia-Pacific, and double-digit percentage growth in the Americas. \n\n\n  In EMEA, net sales declined by a low-single-digit percentage, due to continuing turmoil in the Middle East. Excluding the Middle East, EMEA sales grew by double digits, proving strong underlying regional demand. The company also noted that geopolitical and macroeconomic headwinds continued to weigh on parts of EMEA and Asia-Pacific, and cautioned that persistent or broader challenges could affect sales. \n\n\n  Staar plans to report second-quarter results on August 12. \n\n\n \n\n\n  Write to Doc Louallen at Doc.Louallen@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n\n \n\n\n  Staar Surgical shares retreated after forecasting second-quarter net sales. The company said after the close it expects net sales in excess of $90 million for the second quarter. Analysts are expecting sales of $90.2 million for the quarter, according to FactSet \"Staar Surgical Shares Slide Following Preliminary 2Q Sales,\" at 6:04 p.m. ET on July 16, incorrectly said the company was expecting net sales of $90 million for the second quarter. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 17, 2026 09:53 ET (13:53 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}